Skip to main content

Table 1 Information for the SNPs genotyped in this study

From: Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

Gene

Ref SNP ID

Alleles

MAF

Primer sequences

FGFR1

rs2288696

C/T

0.14

5’-GGTGCCCTATCTGCTCTG-3′,

5’-CTTGGTGGGATGGAAACT-3’

FGFR2

rs2981582

C/T

0.40

5’-TCTGTCATCAGTAGGGAATA-3′,

5’-ATCACCAAGAGGCAGTTC-3’

 

rs1219648

A/G

0.41

5’-ACATCCCTTGTTCTCGTT-3′,

5’-ATTGCCTTGGCTATTCAG-3’

 

rs2420946

T/C

0.44

5’-TTTGGTGGAAGAGTCAGA-3′,

5’-GTCCCAGAGGATTTGTTT-3’

 

rs2981579

T/C

0.49

5’-TGTGACTCCCTTCATCGT-3′,

5’-TGGTCTATTTCTCAATCCCTA-3’

 

rs2981578

G/A

0.37

5’-CTGCTTTGGAGGATTGTGA-3′,

5’-GAGACTGGGAAACAGATGGT-3’

FGFR3

rs743682

G/A

0.17

5’-TACAAAGACCTCGTGAAATGG-3′, 5’-CAAATCCAGACTCGCTTCC-3’

FGFR4

rs1966265

G/A

0.23

5’-GCCGCCTTGTCAGTTGTG-3′,

5’-TCCTGGTGCCCACTCTTCC-3’

  1. SNP single nucleotide polymorphism, MAF minor allele frequency